Neurogene Inc (NGNE)
$27.55 -4.41% Close Oct 30, 2026 Live
Neurogene stock today
Neurogene closed at $27.55 on October 30, 2026, down 4.41% on the day. Over the past year it returned -16.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $435 million.
$20.00$30.00$40.00
NovJan 2026MarMayJulSep
| Period | NGNE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.0% | -0.9% |
| 3 months | -18.0% | +2.1% |
| Year to date | +33.7% | +11.7% |
| 1 year | -16.9% | +12.4% |
| 3 years | +107.5% | +88.5% |
| 5 years | -81.2% | +76.0% |
Key statistics
- Market value
- $435M
- 52-week range
- $16.37 to $42.84
- Next report
- Nov 12, 2026 (estimated)
About Neurogene
Gene therapy company focused on developing treatments for rare neurological and genetic diseases.
Sector: Health Care
More on Neurogene
- Returns: what $1,000 became$1,000 ten years ago is $129.83 today
No forecast, no recommendation. This page describes Neurogene Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.